Primologo
Tagdisability Tagline
Home Assistance Disabilities Fun Sign In
Communication Imp Health Impairment Mental Impairment Mobility Impairment Visual Impairment Cataracts Diabetic Retinopathy Glaucoma Macular Degen Retinal Detachment Retinitis Pigmentosa

Report a Problem

EyeGate Pharma Completes Phase II Study Of EGP-437 In Patients With Anterior Popoff
0 Comments | Share | 33 Views | Problem? | 10/17/09
Linked From Medical News Today : EyeGate Pharma, the leader in non-invasive ocular drug delivery, announces the completion of a Phase II study of its lead product candidate, EGP-437,

Thanks for reporting this problem

We appreciate you notifying us of problem content so we can repair or eliminate it. Reporting problem content is as important as indicating Primo content since both allow us to improve the quality of our site. Please select the specific problem and add additional details in the box if needed.




: